People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the average weight loss seen with semaglutide.
Dozens of obesity and diabetes treatments are in the pipeline, some of which may help people lose even more weight than existing drugs like semaglutide.
The UN agency has received reports of medication falsified to look like the diabetes and weight loss drug Ozempic in at least 3 countries, including the U.S.
Experts with the U.S. Preventive Services Task Force say not enough data has been collected to know whether newer obesity medications for teens are safe.
Americans pay $969 a month for Ozempic, while Canadians pay just $155.
Healthcare company Ro just launched a GLP-1 supply tracker. Eli Lilly is working on one, too
The results of the longest-running trial of semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, are here and looking positive.
The Vermont senator is launching an investigation into why these game-changing diabetes and obesity drugs can cost more than $1,000 a month in America.
New data from Eli Lilly suggests that Zepbound can help people lose weight and have fewer episodes of obstructive sleep apnea at the same time.
Some people fear that new obesity drugs will inevitably prove to be dangerous, but there are key distinctions from the fen-phen crisis of the 1990s.
Roughly 42% of Americans are obese, making the U.S. a huge market for anti-obesity drugs.
In a new Oscar-themed commercial, the drugmaker is telling people to stay away from its blockbuster medications if they’re only looking to lose a few pounds.
Zepbound (tirzepatide) had striking effects on blood pressure in the latest trial data, in addition to helping people shed pounds.
Popular weight loss drugs, painkillers, and other common medications are seeing their list prices go up this month.
Some adverse event reports link alopecia and suicide ideation to GLP-1 drug use, but the FDA says the reports do not prove causation.
Semaglutide and other new drugs are the real deal in obesity treatment, but there are many lingering questions about their future.
There have been nearly 3,000 calls to poison control centers linked to the weight loss drug semaglutide, officials said.
People who stopped taking Zepbound (tirzepatide) regained much of their lost weight within a year, while those on it kept losing more.
People with alcohol use disorder who took semaglutide, also known as Wegovy, drank less and had fewer cravings for alcohol, new research found.
In clinical trials, Eli Lilly's tirzepatide was found to help people lose upwards of 20% of their weight in conjunction with diet and exercise.
Mode
Follow us
